adenosine diphosphate has been researched along with cilostazol in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chijiwa, T; Igawa, T; Kato, S; Kawamura, K; Kimura, Y; Shimidzu, S; Shiragiku, T; Tani, T; Unemi, F | 1 |
| Nakagawa, K; Nishi, T; Shimizu, T; Tabusa, F; Tanaka, T | 1 |
| Kanbe, T; Kimura, Y; Tani, T; Watanabe, K | 1 |
| Adachi, M; Nakano, M; Nakashima, M; Saniabadi, AR; Shimoyama, M; Umemura, K | 1 |
| Nakajima, Y; Nakashima, M; Saniabadi, AR; Takeich, S; Umemura, K; Yukawa, N | 1 |
| Adachi, M; Ikeda, Y; Kondo, K; Nakashima, M; Saniabadi, AR; Suzuki, Y; Umemura, K | 1 |
| Kariyazono, H; Nakamura, K; Sakata, R; Shinkawa, T; Yamada, K; Yamaguchi, T | 1 |
| Ito, H; Kimura, Y; Ozeki, Y; Sudo, T | 1 |
| Huang, MH; Liu, SI; Wu, SN | 1 |
| Iwamoto, T; Kin, K; Miyazaki, K; Shin, K; Takasaki, M | 1 |
| Arima, J; Ayukawa, O; Iguro, Y; Kariyazono, H; Majima, HJ; Masuda, H; Nakamura, K; Onimaru, S; Sakata, R; Yamada, K | 1 |
| Aiura, K; Kitajima, M; Suzuki, K; Ueda, M | 1 |
| Ikegami, M; Matsuda, S; Miyashita, Y; Obara, S; Shimizu, M; Sugiyama, N; Takagi, S; Takizawa, S; Yokoyama, J | 1 |
| Hwang, JY; Hwang, SJ; Jeong, YH; Kim, IS; Kwak, CH; Lee, SW; Park, SW; Park, Y | 1 |
| Hwang, JY; Hwang, SJ; Jeong, YH; Kang, MK; Kim, IS; Kim, S; Koh, EH; Koh, JS; Kwak, CH; Park, JR; Park, KS; Park, Y | 1 |
| Adachi, S; Akamatsu, S; Doi, T; Enomoto, Y; Iwama, T; Kato, K; Kozawa, O; Matsushima-Nishiwaki, R; Natsume, H; Ogura, S; Otsuka, T; Tokuda, H; Yoshimura, S | 1 |
| Hwang, JY; Hwang, SJ; Jeong, YH; Kim, IS; Kim, S; Koh, EH; Kwak, CH; Park, JR; Park, KS; Park, Y; Yun, SE | 1 |
| Behr, T; Behr, W; Kuch, B; von Scheidt, W | 1 |
| Deguchi, I; Fukuoka, T; Hayashi, T; Horiuchi, Y; Kato, Y; Maruyama, H; Nagoya, H; Ohe, Y; Tanahashi, N | 1 |
| Chen, J; Li, X; Lv, Q; Wang, Z; Wu, H; Xue, Y | 1 |
5 trial(s) available for adenosine diphosphate and cilostazol
| Article | Year |
|---|---|
Adenosine 5'-diphosphate as a factor in platelet aggregation induced by human plasma remnant lipoproteins.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Adult; Animals; Apyrase; Chylomicrons; Cilostazol; Female; Guinea Pigs; Hematocrit; Humans; In Vitro Techniques; Lipoproteins, VLDL; Male; Mice; Mice, Inbred ICR; Microscopy, Electron, Scanning; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Rabbits; Rats; Rats, Wistar; Tetrazoles | 1998 |
Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patie
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Blood Vessel Prosthesis Implantation; Cells, Cultured; Chemotherapy, Adjuvant; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine | 2010 |
Cytochrome 2C19 polymorphism and response to adjunctive cilostazol versus high maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention.
Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Blood Platelets; Chemotherapy, Adjuvant; Cilostazol; Clopidogrel; Codon, Nonsense; Cytochrome P-450 CYP2C19; DNA Mutational Analysis; Humans; Ischemia; Platelet Aggregation; Polymorphism, Genetic; Receptors, Purinergic P2Y12; Tetrazoles; Ticlopidine | 2010 |
Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aspirin; Chi-Square Distribution; Cilostazol; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Humans; Korea; Liver; Male; Middle Aged; Myocardial Infarction; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Regression Analysis; Risk Assessment; Risk Factors; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2011 |
Dual antiplatelet therapy clopidogrel with low-dose cilostazol intensifies platelet inhibition in patients with ischemic stroke.
Topics: Adenosine Diphosphate; Aged; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Cilostazol; Clopidogrel; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2Y12; Risk Factors; Tetrazoles; Ticlopidine | 2013 |
15 other study(ies) available for adenosine diphosphate and cilostazol
| Article | Year |
|---|---|
Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Alprostadil; Azoles; Cells, Cultured; Cilostazol; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Thromboxane B2 | 1990 |
Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors, IV. Synthesis and biological activity of the metabolites of 6-[4-(1-cyclohexyl-1H-5-tetrazolyl)butoxy]-2-oxo-1,2,3,4- tetrahydroquinoline (OPC-13013).
Topics: Adenosine Diphosphate; Animals; Azoles; Cilostazol; Collagen; Platelet Aggregation; Rabbits; Structure-Activity Relationship; Tetrazoles | 1985 |
Effect of cilostazol on platelet aggregation and experimental thrombosis.
Topics: Adenosine Diphosphate; Animals; Aspirin; Azoles; Cilostazol; Dogs; Fibrinolytic Agents; Humans; In Vitro Techniques; Mice; Platelet Aggregation; Rabbits; Tetrazoles; Thrombosis; Vasodilator Agents | 1985 |
Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins.
Topics: Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Aspirin; Blood Platelets; Chromatography, Affinity; Chylomicrons; Cilostazol; Erythrocyte Membrane; Hematocrit; Humans; In Vitro Techniques; Lipoproteins; Lipoproteins, VLDL; Male; Microscopy, Electron, Scanning; Middle Aged; Peptide Fragments; Phosphodiesterase Inhibitors; Platelet Adhesiveness; Platelet Aggregation; Tetrazoles | 1997 |
Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Aspirin; Blood Platelets; Cardiovascular Diseases; Cilostazol; Death, Sudden, Cardiac; Disease Susceptibility; Dose-Response Relationship, Drug; Heterozygote; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles | 1998 |
Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol.
Topics: Adenosine Diphosphate; Blood Platelets; Cilostazol; Collagen; Cyclic AMP; Humans; P-Selectin; Phosphodiesterase Inhibitors; Platelet Aggregation; Tetrazoles | 2001 |
Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
Topics: Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Aspirin; Blood Coagulation; Blood Platelets; Cilostazol; Collagen; Dipyridamole; Filtration; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Pressure; Tetrazoles; Time Factors; Tirofiban; Tyrosine | 2001 |
Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC12 cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Adenoma; Adenosine; Adenosine Diphosphate; Animals; Calcium Channels, L-Type; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Electric Conductivity; Enzyme Inhibitors; Kinetics; Large-Conductance Calcium-Activated Potassium Channels; PC12 Cells; Phosphodiesterase Inhibitors; Pituitary Gland, Anterior; Pituitary Neoplasms; Potassium Channels, Calcium-Activated; Rats; Tetrazoles | 2004 |
Recovery of platelet function after withdrawal of cilostazol administered orally for a long period.
Topics: Adenosine Diphosphate; Administration, Oral; Aged; Aged, 80 and over; Blood Platelets; Cilostazol; Female; Humans; In Vitro Techniques; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Time Factors | 2003 |
Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Diphosphate; Arachidonic Acid; Aspirin; Carbazoles; Cilostazol; Collagen; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase Inhibitors; Humans; Microscopy, Confocal; Phosphodiesterase Inhibitors; Plasma; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Reproducibility of Results; Sulfonamides; Tetrazoles | 2004 |
The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents.
Topics: Adenocarcinoma; Adenosine Diphosphate; Adult; Blood Platelets; Cell Line, Tumor; Cilostazol; Collagen; Drug Combinations; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Epoprostenol; Hirudins; Humans; Laminin; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Proteins; Pancreatic Neoplasms; Platelet Activation; Platelet Aggregation Inhibitors; Proteoglycans; Tetrazoles; Thrombin | 2004 |
[Recurrent idiopathic cerebral infarction in a 5-year-old boy, with emphasis on the importance of platelet aggregation analysis for appropriate selection of anti-platelet drugs].
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Tests; Cerebral Infarction; Child, Preschool; Cilostazol; Collagen; Drug Therapy, Combination; Epinephrine; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Tetrazoles; Ticlopidine; Treatment Outcome | 2009 |
cAMP regulates ADP-induced HSP27 phosphorylation in human platelets.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Diphosphate; Blood Platelets; CD40 Ligand; Cilostazol; Cyclic AMP; HSP27 Heat-Shock Proteins; Humans; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Aggregation; Platelet-Derived Growth Factor; Tetrazoles | 2011 |
Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Cerebrovascular Disorders; Cilostazol; Clopidogrel; Drug Monitoring; Drug Resistance; Drug Substitution; Electrodes; Female; Germany; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Stents; Tetrazoles; Thiophenes; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Cilostazol increases adenosine plasma concentration in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Diphosphate; Aged; Aspirin; China; Cilostazol; Clopidogrel; Cyclic AMP; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Function Tests | 2021 |